Simplex Trading’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-53,000
| Closed | -$1.77M | – | 10225 |
|
|
2026
Q1 | $1.77M | Sell |
53,000
-54,000
| -50% | -$2.12M | ﹤0.01% | 1927 |
|
|
2025
Q4 | $4.95M | Buy |
107,000
+47,100
| +79% | +$2.58M | ﹤0.01% | 1271 |
|
|
2025
Q3 | $4.05M | Buy |
59,900
+33,200
| +124% | +$2.46M | ﹤0.01% | 1666 |
|
|
2025
Q2 | $2.24M | Sell |
26,700
-33,500
| -56% | -$2.51M | ﹤0.01% | 1993 |
|
|
2025
Q1 | $4.3M | Buy |
60,200
+15,100
| +33% | +$735K | ﹤0.01% | 1407 |
|
|
2024
Q4 | $2.03M | Buy |
45,100
+41,300
| +1,087% | +$2.14M | ﹤0.01% | 2181 |
|
|
2024
Q3 | $191K | Buy |
3,800
+1,500
| +65% | +$71.8K | ﹤0.01% | 4562 |
|
|
2024
Q2 | $93K | Buy |
2,300
+1,600
| +229% | +$67.8K | ﹤0.01% | 5452 |
|
|
2024
Q1 | $29K | Sell |
700
-19,300
| -97% | -$873K | ﹤0.01% | 6783 |
|
|
2023
Q4 | $805K | Buy |
+20,000
| New | +$569K | ﹤0.01% | 3222 |
|
|
2021
Q4 | – | Sell |
-12,753
| Closed | -$214K | – | 11349 |
|
|
2021
Q3 | $214K | Hold |
12,753
| – | – | ﹤0.01% | 5490 |
|
|
2021
Q2 | $218K | Buy |
12,753
+12,732
| +60,629% | +$215K | ﹤0.01% | 5555 |
|
|
2021
Q1 | $39K | Sell |
21
-1
| -5% | -$32 | ﹤0.01% | 6885 |
|
|
2020
Q4 | $64K | Buy |
22
+21
| +2,100% | +$606 | ﹤0.01% | 5913 |
|
|
2020
Q3 | $3K | Hold |
1
| – | – | ﹤0.01% | 7318 |
|
|
2020
Q2 | $1K | Buy |
+1
| New | +$43 | ﹤0.01% | 7403 |
|
Simplex Trading's SLNO Position: Q2 2026 in Review
Simplex Trading sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 18,166 shares — an estimated $608K sold.
Simplex Trading first reported a position in SLNO in Q4 2020 and held it in 10 quarters. The position peaked at $2.27M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- Simplex Trading reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 18,166 Soleno Therapeutics shares in Q2 2026, an estimated $608K.
- Simplex Trading first reported a position in Soleno Therapeutics in Q4 2020 and held it in 10 quarters.
- Simplex Trading's Soleno Therapeutics position peaked at $2.27M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.